8-K: Arogo Capital Acquisition Corp. Extends Business Combination Deadline with $40,000 Deposit

Arogo Capital Acquisition Corp. has extended its deadline to complete a business combination by one month to October 29, 2024, by depositing $40,000 into its trust account.

Summary

• Arogo Capital Acquisition Corp. has deposited $40,000 into its trust account.
• This deposit extends the deadline for the company to complete its initial business combination by one month, from September 29, 2024, to October 29, 2024.
• This is the thirteenth of a possible fifteen monthly extensions.
• The company intends to file a registration statement on Form F-4, including a proxy statement/prospectus, with the SEC regarding the proposed business combination with Ayurcann Holding Corp.
• Investors are advised to read the proxy statement/prospectus carefully when available.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The extension is a necessary step to complete the business combination, but it also indicates that the initial timeline was not met. The company is taking the necessary steps to move forward.

Positives

• The company has secured an additional month to finalize its business combination.
• The extension demonstrates the company's commitment to completing the transaction.

Risks

• The company's ability to consummate the proposed business combination is not guaranteed.
• The company's forward-looking statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially.

Future Outlook

The company intends to file a registration statement on Form F-4, including a proxy statement/prospectus, with the SEC regarding the proposed business combination with Ayurcann Holding Corp. The company will mail the definitive proxy statement/prospectus to stockholders after the Form F-4 is declared effective by the SEC.

Management Comments

• The company believes that the expectations and assumptions reflected in its forward-looking statements are reasonable, but it cannot guarantee future results.
• The company undertakes no obligation to update, amend or ratify any forward-looking statements because of new information, future events or other factors.

Industry Context

This announcement is typical for SPACs (Special Purpose Acquisition Companies) that are nearing their deadline to complete a business combination. The extension provides more time to finalize the deal with Ayurcann Holding Corp.

Comparison to Industry Standards

• Many SPACs face similar deadlines and often require extensions to complete their business combinations.
• The $40,000 extension payment is a common mechanism to secure additional time.
• The process of filing a Form F-4 and proxy statement is standard for SPAC mergers.

Stakeholder Impact

• Shareholders are impacted by the extension of the business combination deadline.
• Potential investors should carefully review the proxy statement/prospectus when available.

Next Steps

• The company will file a registration statement on Form F-4 with the SEC.
• The company will mail the definitive proxy statement/prospectus to stockholders after the Form F-4 is declared effective by the SEC.
• Stockholders will vote on the proposed business combination.

Key Dates

Keywords

business combination, extension, Arogo Capital Acquisition Corp., Ayurcann Holding Corp., proxy statement, Form F-4, SEC, trust account